Members can also view reports about these policy submissions in past issues of our newsletter [login required].
- Access to new orphan drug therapies and the role of the European Medicines Agency, p4 Sept 2016 newsletter
- Scottish Medicines Consortium assessment of Plenadren, p3, Sept 20116 newsletter
- Never Events, p10, June 2015 newsletter
- Gilmore review of prescription charges, p5, Sept 2009 newsletter
- Darzi review, within the AGM report 2008